Conclusion
REMISSION
Adding AZA to ATD appears to be a promising approach to achieve rapid TSH control and an effective early reduction in TRAb levels, potentially resulting in early and long-lasting remission rates in patients with GD. This combined therapy could offer a novel approach that is cost-effective compared with other options such as thyroidectomy and RAI.